The Middle EAST Hematological Cancers Therapeutics Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.8 billion by 2034, registering a CAGR of 9.5%. This growth trajectory is underpinned by several key factors, including the rising incidence of hematological cancers, advancements in treatment modalities, and increasing healthcare expenditure across the region. The...
Bangla